Chemours (CC) Equity Average (2016 - 2025)
Historic Equity Average for Chemours (CC) over the last 11 years, with Q3 2025 value amounting to $269.5 million.
- Chemours' Equity Average fell 6039.68% to $269.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $269.5 million, marking a year-over-year decrease of 6039.68%. This contributed to the annual value of $663.0 million for FY2024, which is 2813.01% down from last year.
- Latest data reveals that Chemours reported Equity Average of $269.5 million as of Q3 2025, which was down 6039.68% from $409.5 million recorded in Q2 2025.
- In the past 5 years, Chemours' Equity Average registered a high of $1.2 billion during Q3 2022, and its lowest value of $269.5 million during Q3 2025.
- Moreover, its 5-year median value for Equity Average was $833.5 million (2021), whereas its average is $853.3 million.
- As far as peak fluctuations go, Chemours' Equity Average soared by 3632.45% in 2021, and later plummeted by 6039.68% in 2025.
- Quarter analysis of 5 years shows Chemours' Equity Average stood at $1.0 billion in 2021, then increased by 14.94% to $1.2 billion in 2022, then plummeted by 37.83% to $743.5 million in 2023, then dropped by 17.08% to $616.5 million in 2024, then crashed by 56.29% to $269.5 million in 2025.
- Its Equity Average was $269.5 million in Q3 2025, compared to $409.5 million in Q2 2025 and $584.0 million in Q1 2025.